President Trump Signs Memorandum to Crack Down on Big Pharma's Aggressive Drug Advertising

By The Blog Source

A memorandum issued by President Donald Trump on Tuesday instructs federal agencies to combat misleading drug ads and require pharmaceutical corporations to disclose all significant risks and side effects.

According to the memorandum, the Food and Drug Administration will make sure that federal advertising regulations are followed, and Health and Human Services Secretary Robert F. Kennedy Jr. would implement more stringent control of prescription medication marketing.

Trump said marketing expenditure has "skyrocketed" while safety information has decreased, criticizing decades of relaxed restrictions that enabled pharmaceutical companies to reduce warnings in advertisements. Kennedy promised to "shut down that pipeline of deception" after HHS issued around 100 cease-and-desist notices and thousands of warning letters to businesses allegedly deceiving customers.

By signing a memorandum on Tuesday that begins one of the most vigorous crackdowns on drug promotion in American history, President Donald Trump took aim at Big Pharma. With a renewed emphasis on openness, the directive directs the Food and Drug Administration and the Department of Health and Human Services to implement the Food, Drug, and Cosmetic Act's long-standing advertising provisions.

According to Trump's memo, "the FDA has required drugmakers to present both benefits and risks in their ads for years." "However, marketing has exploded, and requirements have loosened over time." He attacked a sector that spends billions on advertising every year yet provides customers with fewer safety facts.

The memo spurred swift action, with HHS announcing that it had sent around 100 cease-and-desist notifications and thousands of warning letters to pharmaceutical firms requesting the removal of deceptive advertisements. In a statement, Kennedy said that pharmaceutical advertisements had "hooked this country on prescription drugs." "We will stop this deceptive practice and mandate that pharmaceutical companies include all important safety information in their advertising."

The action is another step in the administration's efforts to limit corporate influence over public health policy and constitutes a dramatic reversal of decades of advertising practices.

To join the Diamond and Silk Monthly Supporter Program, visit http://SupportDiamondandSilk.com.
Lindell TV, VOCL, ChatDit, Rumble, TruthSocial, and Diamond and Silk Media are all excellent ways to stay connected with Diamond and Silk.